|
C21ORF45 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.832800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.635000E-01 |
| Normal-vs-Stage2 |
1.308020E-01 |
| Normal-vs-Stage3 |
1.638040E-01 |
| Normal-vs-Stage4 |
1.272420E-01 |
| Stage1-vs-Stage2 |
1.026580E-01 |
| Stage1-vs-Stage3 |
1.173960E-01 |
| Stage1-vs-Stage4 |
7.459800E-02 |
| Stage2-vs-Stage3 |
9.256400E-01 |
| Stage2-vs-Stage4 |
9.326800E-01 |
| Stage3-vs-Stage4 |
9.875800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.890770E-01 |
| Normal-vs-AfricanAmerican |
3.518800E-01 |
| Normal-vs-Asian |
3.585000E-01 |
| Caucasian-vs-AfricanAmerican |
3.678100E-02 |
| Caucasian-vs-Asian |
7.242600E-01 |
| AfricanAmerican-vs-Asian |
8.361800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.511570E-01 |
| Normal-vs-Female |
8.326600E-01 |
| Male-vs-Female |
1.532810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.900200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.046400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.012200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.400190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.322400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.506800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.592600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.088250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.892440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.576600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.091590E-02 |
| Normal-vs-Grade 2 |
9.360600E-01 |
| Normal-vs-Grade 3 |
1.040800E-01 |
| Normal-vs-Grade 4 |
2.452500E-02 |
| Grade 1-vs-Grade 2 |
3.008100E-02 |
| Grade 1-vs-Grade 3 |
4.540400E-03 |
| Grade 1-vs-Grade 4 |
1.024030E-03 |
| Grade 2-vs-Grade 3 |
3.814300E-02 |
| Grade 2-vs-Grade 4 |
9.678200E-03 |
| Grade 3-vs-Grade 4 |
2.967600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.002000E-01 |
| Normal-vs-ccB subtype |
1.062320E-02 |
| ccA subtype-vs-ccB subtype |
3.496200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.557000E-01 |
| Normal-vs-N1 |
5.910300E-02 |
| N0-vs-N1 |
1.188370E-01 |
|
|
